Reports of gastrointestinal cancer in Delhi patients as young as 15 have intensified a question that India has not yet answered: how much of the changing cancer profile in its cities is connected to environmental exposure, and how much is explained by diet, lifestyle, infections, family history or genetic susceptibility? Doctors at Sir Ganga Ram Hospital raised the issue at an international conference on colorectal and other GI cancers, while stressing that an association between air pollution and cancer is not proof of direct causation.
The distinction is important. Air pollution is already a major urban governance concern, but linking it to a specific cancer outcome requires long-term evidence that follows exposure and health outcomes over time. The conference therefore brought two issues together: the clinical observation that younger patients are appearing in hospitals, and the research challenge of determining what is driving that change.
Dr Shyam Aggarwal, chairperson of medical oncology at Sir Ganga Ram Hospital and organising chairperson of the conference, said the hospital was seeing new GI cancer patients as young as 15. He said this was uncommon five years ago. The observation is from hospital practice and does not, by itself, establish a population-wide trend across Delhi or India. It does, however, explain why clinicians are calling for a wider investigation rather than relying only on established risk factors.
Dr Saumitra Rawat, chairperson of surgical gastroenterology and GI and HPB onco-surgery at the hospital, said younger patients should be assessed for multiple possible contributors. These include family history, genetic susceptibility, diet, lifestyle, infections and environmental exposures. That approach places air pollution within a broader risk framework instead of presenting it as a single explanation for early-onset disease.
The evidence discussed at the conference points to a plausible area for investigation, but not a settled conclusion. A 2026 review of 70 studies on air pollution and gastrointestinal diseases found that long-term exposure to fine particulate matter, or PM2.5, was associated with higher mortality from GI cancers, with a notable association involving colorectal cancer. A separate study published in Nature Health examined long-term exposure to PM2.5, nitrogen dioxide and ozone in relation to overall cancer risk.
The wording of these findings matters. An association means that two conditions are observed together more often than might otherwise be expected; it does not demonstrate that one directly caused the other. The studies cited in the conference discussion may support further investigation, but they do not establish that Delhi’s air pollution is responsible for the cases being reported by doctors. That conclusion would require India-specific research capable of accounting for several overlapping risks.
This is where the urban dimension becomes central. Pollution exposure is not an isolated medical variable. It is shaped by transport emissions, construction activity, industrial sources, waste burning, weather conditions and the distribution of monitoring stations. Residents may also experience different exposure levels depending on where they live, work, study or travel. Without detailed and sustained exposure data, researchers cannot easily compare the pollution histories of patients and other residents.
The same problem applies to cancer surveillance. The report notes that Indian urban cancer registries have shown a steady increase in colorectal cancer, while hospital studies have reported younger patients being diagnosed at advanced stages. These observations indicate a need for better information, but they do not provide a complete national picture. Hospital data can reveal who reaches a medical facility and how advanced the disease is, while registries are needed to track incidence across defined populations.
The comparison cited at the conference also needs to be read carefully. An analysis of trends in England and India placed the early-onset colorectal cancer rate at 8.4 per 1 lakh among people under 50 in England in 2023, compared with 3.5 per 1 lakh among Indians aged 25 to 49. The populations and age bands described in the comparison are not identical, which limits direct interpretation. The figures nevertheless show why international comparisons require consistent definitions, age groups, reporting systems and years of observation.
For Delhi, the immediate institutional question is whether air-quality monitoring and health surveillance are connected sufficiently to support this kind of research. Experts at the conference called for stronger air-quality monitoring, improved cancer registries and long-term Indian studies examining pollution exposure and clinical outcomes. These demands point to a coordination requirement involving public-health institutions, hospitals, cancer registries, environmental agencies and research organisations.
Air-quality monitoring is usually designed to describe pollution concentrations across locations and time. Cancer surveillance, by contrast, tracks diagnoses, treatment and outcomes. To study a possible link, the two systems would need to be designed to work together, while protecting patient privacy and accounting for other exposures. The supplied report does not establish that such an integrated system currently exists. It does establish that doctors and experts see the absence of India-specific evidence as a significant research gap.
The policy challenge is therefore larger than asking whether pollution causes GI cancer. Policymakers must also determine whether cities are collecting the right data to identify long-term health effects. A monitoring network that records pollutants without connecting exposure patterns to health outcomes can show where air quality is poor, but not necessarily how those exposures affect different groups over time. Similarly, cancer registries that record diagnoses without detailed environmental histories cannot easily test pollution-related hypotheses.
The clinical advice discussed at the conference remains broader than pollution control. Experts stressed timely medical consultation for persistent digestive symptoms, established cancer-prevention measures, appropriate screening and early diagnosis. These measures reflect the uncertainty around causes: while research continues, patients and doctors must work with known risk factors and symptoms rather than wait for a definitive explanation of the environmental contribution.
The age of the patients described by the hospital also raises a separate access question. If younger patients are being diagnosed at advanced stages, the issue may involve awareness, delayed consultation, referral pathways or the availability of appropriate diagnostic services, in addition to the causes of the disease itself. The report does not provide enough evidence to identify which of these factors is most important, but it records the concern that younger patients are presenting with serious illness.
Delhi’s pollution debate is often organised around short-term readings, seasonal peaks and emergency responses. Cancer research operates on a different time scale. Long-term exposure studies require consistent records, comparable measurements and follow-up of health outcomes over years. This difference between the pace of urban pollution and the pace of medical evidence helps explain why public concern can move faster than scientific certainty.
What the evidence currently confirms is limited but important. Delhi doctors are reporting GI cancer patients as young as 15, and experts are calling for environmental exposure to be examined alongside diet, lifestyle, infections, family history and genetics. Research reviewed at the conference has found associations between some pollutants and cancer-related outcomes, but those associations do not prove direct causation. The next meaningful milestones are stronger monitoring, improved registries and long-term Indian studies capable of testing the relationship rather than assuming it.
